COVID-19 and Regenerative Medicine

Published 2020-04-13

AARM is participating in a number of clinical research efforts in the realm of COVID-19 pulmonary disease. AARM sees an urgent need to develop Regenerative Medicine protocols for pulmonary and cardiac regeneration following severe COVID-19 disease. Current data suggests that a significant number of patients who survive severe bilateral COVID-19 pneumonia show residual pulmonary impairment and heart failure.